Integrated multimodal cell atlas of Alzheimer's disease

Mariano I Gabitto,Kyle J Travaglini,Victoria M Rachleff,Eitan S Kaplan,Brian Long,Jeanelle Ariza,Yi Ding,Joseph T Mahoney,Nick Dee,Jeff Goldy,Erica J Melief,Anamika Agrawal,Omar Kana,Xingjian Zhen,Samuel T Barlow,Krissy Brouner,Jazmin Campos,John Campos,Ambrose J Carr,Tamara Casper,Rushil Chakrabarty,Michael Clark,Jonah Cool,Rachel Dalley,Martin Darvas,Song-Lin Ding,Tim Dolbeare,Tom Egdorf,Luke Esposito,Rebecca Ferrer,Lynn E Fleckenstein,Rohan Gala,Amanda Gary,Emily Gelfand,Jessica Gloe,Nathan Guilford,Junitta Guzman,Daniel Hirschstein,Windy Ho,Madison Hupp,Tim Jarsky,Nelson Johansen,Brian E Kalmbach,Lisa M Keene,Sarah Khawand,Mitchell D Kilgore,Amanda Kirkland,Michael Kunst,Brian R Lee,Mckaila Leytze,Christine L Mac Donald,Jocelin Malone,Zoe Maltzer,Naomi Martin,Rachel McCue,Delissa McMillen,Gonzalo Mena,Emma Meyerdierks,Kelly P Meyers,Tyler Mollenkopf,Mark Montine,Amber L Nolan,Julie K Nyhus,Paul A Olsen,Maiya Pacleb,Chelsea M Pagan,Nicholas Peña,Trangthanh Pham,Christina Alice Pom,Nadia Postupna,Christine Rimorin,Augustin Ruiz,Giuseppe A Saldi,Aimee M Schantz,Nadiya V Shapovalova,Staci A Sorensen,Brian Staats,Matt Sullivan,Susan M Sunkin,Carol Thompson,Michael Tieu,Jonathan T Ting,Amy Torkelson,Tracy Tran,Nasmil J Valera Cuevas,Sarah Walling-Bell,Ming-Qiang Wang,Jack Waters,Angela M Wilson,Ming Xiao,David Haynor,Nicole M Gatto,Suman Jayadev,Shoaib Mufti,Lydia Ng,Shubhabrata Mukherjee,Paul K Crane,Caitlin S Latimer,Boaz P Levi,Kimberly A Smith,Jennie L Close,Jeremy A Miller,Rebecca D Hodge,Eric B Larson,Thomas J Grabowski,Michael Hawrylycz,C Dirk Keene,Ed S Lein

DOI: https://doi.org/10.1038/s41593-024-01774-5

2024-10-14

Abstract:Alzheimer's disease (AD) is the leading cause of dementia in older adults. Although AD progression is characterized by stereotyped accumulation of proteinopathies, the affected cellular populations remain understudied. Here we use multiomics, spatial genomics and reference atlases from the BRAIN Initiative to study middle temporal gyrus cell types in 84 donors with varying AD pathologies. This cohort includes 33 male donors and 51 female donors, with an average age at time of death of 88 years. We used quantitative neuropathology to place donors along a disease pseudoprogression score. Pseudoprogression analysis revealed two disease phases: an early phase with a slow increase in pathology, presence of inflammatory microglia, reactive astrocytes, loss of somatostatin+ inhibitory neurons, and a remyelination response by oligodendrocyte precursor cells; and a later phase with exponential increase in pathology, loss of excitatory neurons and Pvalb+ and Vip+ inhibitory neuron subtypes. These findings were replicated in other major AD studies.